France-Denmark Bilateral Trade Analysis 2023

Complete trade statistics: $9.65B total volume โ€ขFrance deficit: $945.24M

France โ†’ Denmark

$4.35B

Exports (2023)

Denmark โ†’ France

$5.30B

Imports (2023)

Trade Balance

$945.24M

Deficit for France

Total Trade

$9.65B

Combined Volume

Trade Flow Visualization

Direct trade relationship between France and Denmark. Green line shows exports from France, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the France-Denmark commercial relationship and competitive positioning in global markets.

France โ†’ Denmark Exports

$4.35B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
9.0% top product
1Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale
$392.88M
9.0% of exports
2Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg
$325.77M
7.5% of exports
3Wine: still, in containers holding 2 litres or less
$166.59M
3.8% of exports
4Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$160.01M
3.7% of exports
5Petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils
$67.74M
1.6% of exports
6Wine: sparkling
$63.38M
1.5% of exports
7Vehicles: with only electric motor for propulsion
$61.61M
1.4% of exports
8Machinery: for filtering or purifying liquids, n.e.c. in item no. 8421.2
$59.98M
1.4% of exports
9Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations)
$56.41M
1.3% of exports
10Dairy produce: cheese (not grated, powdered or processed), n.e.c. in heading no. 0406
$54.81M
1.3% of exports

๐ŸŽฏ Strategic Export Focus

France's export portfolio to Denmark demonstrates strong diversification across multiple sectors, with medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.

Denmark โ†’ France Imports

$5.30B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
6.8% concentration
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$358.31M
6.8% of imports
2Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale
$320.79M
6.1% of imports
3Electric motors and generators: parts suitable for use solely or principally with the machines of heading no. 8501 or 8502
$214.12M
4.0% of imports
4Electric generators: AC generators, (alternators), of an output exceeding 750kVA
$114.48M
2.2% of imports
5Fish: fresh or chilled, Atlantic salmon (Salmo salar) and Danube salmon (Hucho hucho), excluding fillets, fish meat of 0304, and edible fish offal of subheadings 0302.91 to 0302.99
$92.09M
1.7% of imports
6Pumps: parts thereof
$77.35M
1.5% of imports
7Enzymes and prepared enzymes: other than rennet and concentrates thereof
$73.99M
1.4% of imports
8Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts
$65.49M
1.2% of imports
9Jewellery: of silver, whether or not plated or clad with other precious metal, and parts thereof
$65.41M
1.2% of imports
10Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
$58.47M
1.1% of imports

๐Ÿ“ฆ Import Strategy Analysis

France's import pattern from Denmark reveals strategic sourcingin medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

๐Ÿ†

Market Leadership

France demonstrates competitive strength in exportingmedicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale to Denmark, leveraging comparative advantages.

Export Leader in 20+ Categories
๐Ÿ”„

Trade Complementarity

The bilateral relationship showsstrongcomplementarity, with each country specializing in different sectors.

Highly Balanced
๐Ÿ“ˆ

Growth Potential

The $9.65B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Significant Partnership

Executive Summary: France-Denmark Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $9.65 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: France maintains a deficit of $945.24 million
  • Export Focus: France's primary exports include medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale, aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg, wine: still, in containers holding 2 litres or less
  • Import Dependencies: Key imports from Denmark include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale, electric motors and generators: parts suitable for use solely or principally with the machines of heading no. 8501 or 8502

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthBalanced

๐Ÿ“ˆ Market Position: This bilateral trade relationship represents an important regional trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $9.65B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with France leveraging its comparative advantages in medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

France's specialization in medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail salecomplements Denmark's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $9.65B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyModerate
๐Ÿ”ฎ

Trade Relationship Outlook

The $9.65B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

๐Ÿ’ฐ

Trade Volume Impact

The $9.65 billion bilateral trade volume represents a important trade relationshipfor both economies.

Economic Significance: Moderate
๐Ÿญ

Industrial Integration

Trade flows in medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale and medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
โš–๏ธ

Trade Balance Effects

France's trade deficit of $945.24 million impacts its overall economic position in this bilateral relationship.

Balance Impact: Well Balanced

Strategic Future Outlook

๐Ÿš€Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg present expansion opportunities.
Market Diversification
Beyond current focus on medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, new product categories offer potential for trade expansion.

โš ๏ธRisk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale may affect future market positioning.

๐ŸŽฏStrategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between France and Denmark represents a total trade volume of $9.65 billion in 2023. This partnership demonstrates an unfavorable trade balance for France, with imports exceeding exportsby $945.24 million.

Export Strengths

France's exports to Denmark total $4.35 billion, with competitive advantages in medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale, representing $392.88M or9.0% of bilateral exports.

Import Dependencies

Imports from Denmark amount to $5.30 billion, highlighting economic interdependence in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, with Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale comprising6.8% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade deficit indicates France's strategic sourcing from Denmark. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between France and Denmark in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) โ€ข Last Updated: January 2025 โ€ข Coverage: 1995-2023